We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment

News   Sep 11, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment
 
 
 

RELATED ARTICLES

New Study of HIV Vaccine Shows Promising Results Across Strains

News

Using the same RV 144 HIV vaccine employed in Thailand, a new study has evaluated whether the vaccine-induced immune responses to RV 144 are similar in a South African cohort.

READ MORE

Mutating Ebola Virus Protein Works as a Vaccine to Protect Animals From Infection

News

Creating mutations in a key Ebola virus protein that helps the deadly virus escape from the body's defenses can make the virus unable to produce sickness and activate protective immunity in the infected host, according to a study by the Institute for Biomedical Sciences at Georgia State University.

READ MORE

New Technique Rapidly Detects Skin Cancer

News

Researchers at Stevens Institute of Technology have developed a technique that detects skin lesions and determines whether they are cancerous or benign – a technology that could ultimately be incorporated into a handheld device that could rapidly diagnose skin cancer without a scalpel in sight.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Diagnostics Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE